Translation of our research findings is central to our research programme. We work closely with our clinical and industrial partners to achieve this aim.
Some of our on-going activities include:
- Cancer genetic profiling. We are now working with industry to deliver this genetic test to patients with breast cancer
- Genetic testing and new therapies for patients with difficult and non-healing wounds and are currently in the process of producing a ‘Wound Genetics Prognostic Kit'
We have a range of other technologies including genetic testing in other cancer types and new therapeutics for cancer under development.